当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析

西藏药业

(600211)

  

流通市值:150.52亿  总市值:150.52亿
流通股本:3.22亿   总股本:3.22亿

西藏药业(600211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润5.71亿元,每股收益1.76元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益419764.78万元,未分配利润241474.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产566316.48万元,负债146551.69万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,650,705,155.36712,108,915.52,806,713,295.852,175,443,351.59
营业总成本1,032,761,299.84424,599,500.371,865,690,7891,408,185,831.63
其他经营收益
营业利润638,690,965.16302,515,530.491,160,450,276.72884,452,957.66
利润总额637,320,433.54301,647,438.611,152,084,060.44882,826,441.17
净利润570,788,875.89270,248,719.591,057,075,195.66795,146,775.01
每股收益
其他综合收益-4,937,939.25-1,616,882.116,352,053.8-12,079,404.53
综合收益总额565,850,936.64268,631,837.491,073,427,249.46783,073,875.81
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计4,221,930,832.024,065,129,050.443,569,908,233.163,492,491,291.76
非流动资产:
非流动资产合计1,441,233,924.081,157,073,560.111,177,430,107.971,178,542,722.44
资产总计5,663,164,756.15,222,202,610.554,747,338,341.134,671,034,014.2
流动负债:
流动负债合计1,437,211,036.531,052,839,917.62766,571,363.98976,373,627.13
非流动负债:
非流动负债合计28,305,877.4433,073,375.2728,661,867.6230,935,156.52
负债合计1,465,516,913.971,085,913,292.89795,233,231.61,007,308,783.65
所有者权益(或股东权益):
归属于母公司股东权益合计4,161,105,707.944,101,032,390.123,917,816,533.713,629,963,702.7
股东权益合计4,197,647,842.134,136,289,317.663,952,105,109.533,663,725,230.55
负债和股东权益合计5,663,164,756.15,222,202,610.554,747,338,341.134,671,034,014.2
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,694,938,622.22835,746,973.163,532,316,583.782,783,019,017.98
经营活动现金流出小计1,094,723,350.6525,937,027.592,537,525,771.962,035,757,009.53
经营活动产生的现金流量净额600,215,271.62309,809,945.57994,790,811.82747,262,008.45
投资活动产生的现金流量:
投资活动现金流入小计2,301,977,179.021,056,215,668.244,912,682,591.623,577,250,394.8
投资活动现金流出小计2,700,270,233.91,354,801,433.234,558,196,774.613,406,174,323.24
投资活动产生的现金流量净额-398,293,054.88-298,585,764.99354,485,817.01171,076,071.56
筹资活动产生的现金流量:
筹资活动现金流入小计596,260,372.15243,970,643.18534,947,148.22434,048,862.95
筹资活动现金流出小计493,570,713.6485,526,605.531,267,939,919.431,050,332,572.98
筹资活动产生的现金流量净额102,689,658.51158,444,037.65-732,992,771.21-616,283,710.03
汇率变动对现金及现金等价物的影响-4,034,954.9-1,358,179.417,437,746.19-6,913,756.98
现金及现金等价物净增加额300,576,920.35168,310,038.82623,721,603.81295,140,613
期末现金及现金等价物余额1,606,478,086.41,474,211,204.871,305,901,166.05977,320,175.24
补充资料:
现金及现金等价物的净增加额300,576,920.35-623,721,603.81-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华鑫证券吴景欢,胡博新2.773.003.312025-08-29
首创证券王斌3.053.243.572025-08-20
TOP↑